Compare Adaptive Biotechnologies Corp (ADPT) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Western Digital Corp — how do they compare? Adaptive Biotechnologies Corp trades at $24.96 (market cap $4.04B), while Western Digital Corp trades at $460.3 (market cap $150.95B). The key difference: Western Digital Corp is far larger — about 37.4× Adaptive Biotechnologies Corp's market cap, and Western Digital Corp pays a 0.14% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | WDC | |
|---|---|---|
Market Cap | $4.04B | $150.95B |
Sector | Health | Technology |
52-Week High | $25.45 | $746.23 |
52-Week Low | $12.30 | $74.66 |
Enterprise Value | $4.10B | $150.42B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $24.94, down 2.0% today but near its 52-week high. The stock shows a bullish technical trend with improving fundamentals, including 49% MRD revenue growth and narrowing losses. A recent 4:1 reverse stock split and planned business separation aim to unlock value, with analyst consensus leaning bullish.
Outlook is cautiously optimistic due to strong revenue growth and margin expansion, but risks persist from ongoing net losses and competitive pressures. The stock offers potential upside to the $25.50 consensus target if execution continues improving, yet volatility may remain until profitability is achieved.
Western Digital (WDC) trades at $454.34, up 3.7% in the last 24 hours, with strong earnings beats in recent quarters and a bullish analyst consensus of 72% buy ratings. The stock faces bearish technical signals but benefits from robust AI-driven storage demand, evidenced by 44% revenue growth in Q4 2026 and a net income margin of 72.95% in 2025. Recent news highlights its positioning as a key player in AI infrastructure, though valuation concerns persist.
The outlook for WDC is positive due to sustained AI storage demand and margin expansion, but risks include high valuation multiples and cyclical industry pressures. With a consensus price target of $665.15, upside potential exists, yet investors should monitor competitive threats and earnings sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
